» Articles » PMID: 31397022

The Impact of an Epilepsy Nurse Competency Framework on the Costs of Supporting Adults with Epilepsy and Intellectual Disability: Findings from the EpAID Study

Overview
Specialty Psychiatry
Date 2019 Aug 10
PMID 31397022
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The development of a nurse-led approach to managing epilepsy in adults with an intellectual disability (ID) offers the potential of improved outcomes and lower costs of care. We undertook a cluster randomised trial to assess the impact on costs and outcomes of the provision of ID nurses working to a designated epilepsy nurse competency framework. Here, we report the impact of the intervention on costs.

Method: Across the United Kingdom, eight sites randomly allocated to the intervention recruited 184 participants and nine sites allocated to treatment as usual recruited 128 participants. Cost and outcome data were collected mainly by telephone interview at baseline and after 6 months. Total costs at 6 months were compared from the perspective of health and social services and society, with adjustments for pre-specified participant and cluster characteristics at baseline including costs. Missing data were imputed using multiple imputation. Uncertainty was quantified by bootstrapping.

Results: The intervention was associated with lower per participant costs from a health and social services perspective of -£357 (2014/2015 GBP) (95% confidence interval -£986, £294) and from a societal perspective of -£631 (95% confidence interval -£1473, £181). Results were not sensitive to the exclusion of accommodation costs.

Conclusions: Our findings suggest that the competency framework is unlikely to increase the cost of caring for people with epilepsy and ID and may reduce costs.

Citing Articles

Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations.

Mukherjee K, Gunsoy N, Kristy R, Cappelleri J, Roydhouse J, Stephenson J Pharmacoeconomics. 2023; 41(12):1589-1601.

PMID: 37490207 PMC: 10635950. DOI: 10.1007/s40273-023-01297-0.


Further advances in epilepsy.

Fawcett J, Davis S, Manford M J Neurol. 2023; 270(11):5655-5670.

PMID: 37458794 DOI: 10.1007/s00415-023-11860-6.


A structural equation modelling analysis: interprofessional team collaboration, organizational career management, and post competency of community nurses.

Ma L, Wang X, Zou S, Lin M, Qiu S, Li W BMC Health Serv Res. 2023; 23(1):327.

PMID: 37005581 PMC: 10067220. DOI: 10.1186/s12913-023-09303-z.

References
1.
Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C . Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technol Assess. 2013; 17(7):1-166. PMC: 4782811. DOI: 10.3310/hta17070. View

2.
Halcomb E, Stephens M, Bryce J, Foley E, Ashley C . Nursing competency standards in primary health care: an integrative review. J Clin Nurs. 2016; 25(9-10):1193-205. DOI: 10.1111/jocn.13224. View

3.
Kinnear D, Morrison J, Allan L, Henderson A, Smiley E, Cooper S . Prevalence of physical conditions and multimorbidity in a cohort of adults with intellectual disabilities with and without Down syndrome: cross-sectional study. BMJ Open. 2018; 8(2):e018292. PMC: 5829598. DOI: 10.1136/bmjopen-2017-018292. View

4.
Devlin N, Shah K, Feng Y, Mulhern B, van Hout B . Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 2017; 27(1):7-22. PMC: 6680214. DOI: 10.1002/hec.3564. View

5.
Buck D, Smith M, Appleton R, Baker G, Jacoby A . The development and validation of the Epilepsy and Learning Disabilities Quality of Life (ELDQOL) scale. Epilepsy Behav. 2006; 10(1):38-43. DOI: 10.1016/j.yebeh.2006.10.010. View